Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group 
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector 
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm 
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role 
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement 
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties 
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip 
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 
Italy Fines Apple €98.6 Million Over App Store Dominance 
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants 
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions 
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling 
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift 
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project 
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training 
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow 
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026 
DENVER, Oct. 17, 2016 -- BioScrip, Inc. (NASDAQ:BIOS) announced today that the Company will release its 2016 third quarter financial results on Monday, November 7, 2016, after the close of the U.S. financial markets.
Daniel E. Greenleaf, President and Chief Executive Officer, and Jeffrey M. Kreger, Senior Vice President, Chief Financial Officer and Treasurer, will conduct a conference call as follows:
| Date | Tuesday, November 8, 2016 | |
| Time | 11:00 a.m. Eastern Time | |
| Toll free (U.S.) | (888) 372-9592 | |
| Webcast (live and replay) | www.bioscrip.com | |
A replay of the conference call will be available for one week after the call's completion by dialing (855) 859-2056 (US) and entering conference call ID number 1061955.
About BioScrip, Inc.
BioScrip, Inc. is a leading national provider of infusion and home healthcare management solutions. BioScrip partners with healthcare providers, including physicians, hospital systems, skilled nursing facilities, and with healthcare payors to provide patients better access to high quality, efficient post-acute care services. BioScrip operates with a commitment to bring infusion therapy services into the home or alternate-site settings. By collaborating with the full spectrum of healthcare professionals and the patient, BioScrip provides cost-effective care that is driven by clinical excellence, customer service, and values that promote positive outcomes and an enhanced quality of life for those it serves.
Contact: Jeffrey M. Kreger Chief Financial Officer T: (720) 697-5200 [email protected]
